Data through FY2026 Q3 (Jun 30, 2026)
Enveda Therapeutics, Inc.
Company profile for Enveda Therapeutics, Inc. covers 8 filings across the reporting window. FY2026 certified median offer: $178,800.
- FY2026 certified median
- $178,800
- Total filings
- 8
- FY2026 25th–75th percentile
- $166,325–$220,625
- Top job title
- Biomarker Operations Manager
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 2 | $120,000 | $105,000 | $135,000 |
| FY2025 | 2 | $222,500 | $203,750 | $241,250 |
| FY2026 (Q1–Q3) | 4 | $178,800 | $166,325 | $220,625 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Biomarker Operations Manager2 filings
- Associate Vice President1 filings
- Cosmetics Project Manager1 filings
- Senior CMC Project Manager1 filings
- Sr. Manager, Business Development1 filings
- Sr. Software Engineer1 filings
- VP, Corporate Development1 filings
Top cities
- Boulder2 filings
- Lebanon2 filings
- San Francisco1 filings
- Jersey City1 filings
- New York1 filings
- Spring1 filings